Biotech · Private company
Elpida Therapeutics SPC
Track this companyFree. Adds Elpida Therapeutics SPC to your Dealase workspace and tells you when its record changes.
Clinical trials55 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MELPIDAPhase 3 · Hereditary Spastic Paraplegia Type 50ClinicalTrials.gov · fetched Nov 12, 2026
- ELP-02Phase 2 · Charcot-Marie-Tooth Disease Type 4JClinicalTrials.gov · fetched Nov 12, 2026
- MELPIDAPhase 2 · Spasticity, MuscleClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)PHASE1_PHASE2 · RECRUITING · started Aug 7, 2026ClinicalTrials.gov NCT07447557 · fetched Nov 12, 2026
- Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.PHASE3 · RECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT06692712 · fetched Nov 12, 2026
- A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora DiseasePHASE1_PHASE2 · RECRUITING · started Dec 3, 2024ClinicalTrials.gov NCT06609889 · fetched Nov 12, 2026
- A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4JACTIVE_NOT_RECRUITING · started Jul 29, 2024ClinicalTrials.gov NCT06151600 · fetched Nov 12, 2026
- Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)PHASE1_PHASE2 · RECRUITING · started Feb 15, 2023ClinicalTrials.gov NCT05518188 · fetched Nov 12, 2026